Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06633029 · ClinicalTrials.gov registry record
Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
A clinical trial of Acute Kidney Injury (AKI) and Fluid Overload in Dialysis Patients, sponsored by Vantive Health.
- Completed
- Registry status
- 59
- Enrollment target
- 5
- Study locations
NCT06633029: Completed study of Acute Kidney Injury (AKI) and Fluid Overload in Dialysis Patients, sponsored by Vantive Health.
NCT06633029 is a study of Acute Kidney Injury (AKI) and Fluid Overload in Dialysis Patients that has completed, run by Vantive Health. The registered enrollment target is 59 participants, below the 4,623-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06633029, a study of Acute Kidney Injury (AKI) and Fluid Overload in Dialysis Patients, has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 5
- Study locations
Study Summary
A retrospective multicenter, observational design intended to capture data on pediatrics (weighing between 8 - 20 kg) who underwent continuous renal replacement therapy (CRRT) using the HF20 set. Data will be compared with a similar population (weighting 8-20 kg) from the ppCRRT registry who received CRRT with Prismaflex M60 sets.
Primary Outcome
The proportion of patients who completed HF20/M60 based CRRT
Conditions Studied
Interventions
- DEVICE Prismaflex HF20
Study Locations (5)
Alabama
- University of Alabama at Birmingham / Children's of Alabama - Birmingham
California
- Lucile Packard Children's Hospital Stanford - Palo Alto
Illinois
- Ann and Robert H Lurie Children's Hospital of Chicago - Chicago
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Washington
- Seattle Children's Hospital Research and Foundation - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2024-12-11 |
| Est. Completion | 2025-06-25 |
What the finished NCT06633029 record still lists
NCT06633029 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 4,623-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Acute Kidney Injury (AKI) appearing as the primary indexed condition, and to 1 intervention - of which Prismaflex HF20 is the first listed.
NCT06633029 lists 5 locations in 5 states (Alabama, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT06633029 about?
NCT06633029 is a clinical study titled "Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry". A retrospective multicenter, observational design intended to capture data on pediatrics (weighing between 8 - 20 kg) who underwent continuous renal replacement therapy (CRRT) using the HF20 set. Data will be compared with a similar population (weighting 8-20 kg) from the ppCRRT registry who receive...
What is the current status of trial NCT06633029?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2024-12-11. Estimated completion is 2025-06-25.
What conditions does trial NCT06633029 study?
This clinical trial studies the following conditions: Acute Kidney Injury (AKI), Fluid Overload in Dialysis Patients, Acute Renal Failure (ARF).
What interventions are being tested in trial NCT06633029?
The interventions under investigation include: Prismaflex HF20 (DEVICE).
Who is sponsoring clinical trial NCT06633029?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06633029 being conducted?
This trial has 5 study locations across Alabama, California, Illinois, Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury (AKI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
RECRUITING · Phase 3
-
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
RECRUITING · Phase 4
-
NIRS Monitoring in the NICU and AKI
RECRUITING · NA
-
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI